Gordion Bioscience
MOTIVATED TO MAKE BETTER DRUGS - POWERED WITH TUMOR DATA - DELIVERED BY MACHINE LEARNING
MOTIVATED TO MAKE BETTER DRUGS - POWERED WITH TUMOR DATA - DELIVERED BY MACHINE LEARNING
Gordion Bioscience is a groundbreaking startup that is expertly combining genomics, machine learning, and oncology to lead the way in innovative cancer treatment research. Founded in 2023, the company brings together profound knowledge in genomics, machine learning, and oncology, propelling it to the forefront of research and innovation in cancer treatment. Gordion Bioscience operates within the Biopharma, Biotechnology, and Health Care industries. Notably, the company recently received a $120.00K Pre Seed Round investment from Techstars on 09 October 2023. With such promising advancements and significant backing, Gordion Bioscience is poised to make a considerable impact in the field of cancer treatment research.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Pre Seed Round | $120.00K | 1 |
|
09 Oct 2023 |
We care about your data, and we'd love to use cookies make your experience better.
